Sarepta therapeutics to announce third quarter 2023 financial results

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, will report third quarter 2023 financial results after the nasdaq global market closes on wednesday, nov. 1, 2023. subsequently, at 4:30 p.m. e.t., the company will host a conference call to discuss its third quarter 2023 financial results. the event will be webcast live under the investor relations section of sarepta's website at https://investorrelations.sar.
SRPT Ratings Summary
SRPT Quant Ranking